Clinical outcomes of baricitinib in patients with systemic lupus erythematosus: Pooled analysis of SLE-BRAVE-I and SLE-BRAVE-II trials. Yin J, Hou Y, Wang C, Qin C, et al. PLoS One 2025;20:e0320179.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yin J, Hou Y, Wang C, Qin C, et al. Clinical outcomes of baricitinib in patients with systemic lupus erythematosus: Pooled analysis of SLE-BRAVE-I and SLE-BRAVE-II trials. PLoS One 2025;20:e0320179.
PMID: 40305472